Global Next Generation Sequencing Market Growth (Status and Outlook) 2023-2029

Global Next Generation Sequencing Market Growth (Status and Outlook) 2023-2029

Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.

LPI (LP Information)' newest research report, the “Next Generation Sequencing Industry Forecast” looks at past sales and reviews total world Next Generation Sequencing sales in 2022, providing a comprehensive analysis by region and market sector of projected Next Generation Sequencing sales for 2023 through 2029. With Next Generation Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Next Generation Sequencing industry.

This Insight Report provides a comprehensive analysis of the global Next Generation Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Next Generation Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Next Generation Sequencing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Next Generation Sequencing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Next Generation Sequencing.

The global Next Generation Sequencing market size is projected to grow from US$ 3609.9 million in 2022 to US$ 4601.3 million in 2029; it is expected to grow at a CAGR of 3.5% from 2023 to 2029.

The classification of Next-Generation Sequencing (NGS) Services includes Targeted Sequencing, Whole Exome Sequencing and Whole Genome Sequencing, and the proportion of Targeted Sequencing in 2019 is about 55%.

Next-Generation Sequencing (NGS) Services is widely used in Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations and Other. The most proportion of Next-Generation Sequencing (NGS) Services is Hospitals and Clinics, and the proportion in 2019 is about 56%.

North America is the largest consumption place, with a consumption market share nearly 37% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of about 32%.

Eurofins Scientific, Natera, BGI, Illumina, etc. are the leaders of the industry.

This report presents a comprehensive overview, market shares, and growth opportunities of Next Generation Sequencing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Targeted Sequencing & Resequencing
Whole Genome Sequencing
Whole Exome Sequencing

Segmentation by application
Whole-genome Sequencing
Exome Sequencing
Targeted Resequencing
De Novo Sequencing
RNA Sequencing
ChIP Sequencing
Methyl Sequencing
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
454 Life Sciences Corporation (A Roche Company)
Agilent Technologies
Biomatters, Ltd
CLC Bio
GATC biotech AG
Macrogen
BGI (Beijing Genomics Institute)
Illumina
Life Technology Corporation
EMC Corporation
Dnastar

Please note: The report will take approximately 2 business days to prepare and deliver.